Alzheimer's Disease Trial, Recruiting NCT05295615 Sponsor: Herrick Medical LLC Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05295615
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 50 years of age or older
  • People who have been diagnosed with mild to moderate Alzheimer's dementia
  • People who completed at least an eighth grade level of education
  • Women who have gone through menopause
  • People whose score on a standard memory and thinking test (called the MMSE) falls between 16 and 26
  • People who are able to give their own consent to join the study, or who have a spouse, family member, or other representative able to give consent on their behalf
  • People who are willing and able to follow the study's requirements
  • People who are taking a cholinesterase inhibitor and/or memantine, provided that medication was prescribed at least 3 months before the screening visit and the dose has been stable for at least 60 days before screening, and can remain at that dose for the whole study
  • People who have a spouse, family member, or professional caregiver who agrees to and is capable of supporting the person's participation — including answering questions about their condition, managing their medication, and applying and supervising the daily treatment sessions
  • People who a clinician has assessed as physically suitable to take part in the study

Who may not be able to join:

  • People who cannot give their own consent and do not have a surrogate available to consent on their behalf
  • People with a history of epilepsy or epileptic seizures
  • People currently taking medication that lowers the threshold for seizures
  • People who have a current or past diagnosis of depression, bipolar disorder, a psychotic disorder, or any other neurological or psychiatric condition that the study investigator considers would interfere with the study
  • People experiencing severe agitation that would interfere with study procedures
  • People who have had an alcohol or substance use disorder (as defined by DSM-5) within the last 5 years, or who are experiencing severe sleep deprivation
  • People who have had major surgery — defined as major abdominal, vascular, or chest surgery requiring general anaesthesia and resulting in more than one week in hospital — within the past 4 weeks
  • People whose head shape or size prevents the treatment device from fitting properly
  • People who have taken part in another clinical trial within the past 30 days
  • People who have metal implants in the head, such as cochlear implants, implanted brain stimulators, neurostimulators, or aneurysm clips (note: metal implants in the mouth are generally not excluded — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 551-996-1140

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Herrick Medical LLC
Registry
ClinicalTrials.gov
Start date
1 May 2023
Est. completion
30 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog); Mini-Mental Status Exam (MMSE); Global Deterioration questionnaire; Quality of Life Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov